REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 45 filers reported holding REDHILL BIOPHARMA LTD in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,940 | -84.2% | 28,084 | -42.7% | 0.00% | – |
| Q3 2022 | $25,000 | -41.9% | 48,984 | +0.2% | 0.00% | – |
| Q2 2022 | $43,000 | 0.0% | 48,895 | +187.5% | 0.00% | – |
| Q1 2022 | $43,000 | -42.7% | 17,007 | -41.3% | 0.00% | – |
| Q4 2021 | $75,000 | -75.7% | 28,995 | -57.1% | 0.00% | – |
| Q3 2021 | $309,000 | +68.9% | 67,532 | +276.9% | 0.00% | -100.0% |
| Q3 2020 | $183,000 | -54.6% | 17,919 | -70.2% | 0.00% | -50.0% |
| Q2 2020 | $403,000 | +227.6% | 60,194 | +122.3% | 0.00% | +100.0% |
| Q1 2020 | $123,000 | -25.5% | 27,082 | -0.4% | 0.00% | 0.0% |
| Q4 2019 | $165,000 | +1962.5% | 27,182 | +2371.1% | 0.00% | – |
| Q3 2019 | $8,000 | +166.7% | 1,100 | +188.7% | 0.00% | – |
| Q1 2019 | $3,000 | -57.1% | 381 | -70.3% | 0.00% | – |
| Q4 2018 | $7,000 | -46.2% | 1,281 | -10.8% | 0.00% | – |
| Q3 2018 | $13,000 | – | 1,436 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ibex Investors LLC | 444,301 | $2,284,000 | 1.33% |
| 683 Capital Management, LLC | 999,232 | $5,136,000 | 0.43% |
| DAFNA Capital Management LLC | 35,000 | $180,000 | 0.10% |
| MENORA MIVTACHIM HOLDINGS LTD. | 421,000 | $2,164,000 | 0.08% |
| Migdal Insurance & Financial Holdings Ltd. | 397,324 | $2,042,000 | 0.05% |
| Claret Asset Management Corp | 42,522 | $219,000 | 0.05% |
| Orbimed Advisors | 564,900 | $2,904,000 | 0.04% |
| Altshuler Shaham Ltd | 169,446 | $251,000 | 0.04% |
| Virtu Financial LLC | 60,787 | $312,000 | 0.02% |
| MEITAV INVESTMENT HOUSE LTD | 48,000 | $244,000 | 0.01% |